⟵ Back to Search Results

BGB-900-102 U1111-1278-0027

Recruiting

Study of BGB-A425 in Combination With Tislelizumab in Advanced Solid Tumors

Beigene Study ID info

BGB-900-102 U1111-1278-0027

ClinicalTrials.gov ID info

NCT03744468

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents

Locations

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents